Standard practice includes: Baseline thyroid function tests (TSH and free T4) before initiating GLP-1 therapy Repeat testing at 812 weeks after starting treatment or after dose escalation Regular monitoring every 36 months during active weight loss Return to annual monitoring once weight is stable and thyroid function remains consistent Adjustments to levothyroxine dosing may be necessary as weight changes
They can assess whether the symptoms might be related to the medication, explore other contributing factors, and determine the most appropriate course of action
Zhu, N., Liang, X., Zhang, M., Yin, X., Yang, H., Zhi, Y., & Li, H
Functional hypothalamic amenorrhea and its influence on women's health
Longevity treatments Trava recently added NAD+ and sermorelin to their treatment menu
Human outcome data is limited